XORTX Therapeutics Inc
NASDAQ:XRTX
Income Statement
Earnings Waterfall
XORTX Therapeutics Inc
Income Statement
XORTX Therapeutics Inc
| Nov-2013 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
814
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
(643)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
171
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(170)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(7)
|
(9)
|
(11)
|
(10)
|
(10)
|
(8)
|
(8)
|
(6)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
|
| Selling, General & Administrative |
(69)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
|
| Research & Development |
(98)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
(5)
|
(6)
|
(7)
|
(6)
|
(5)
|
(4)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
1
N/A
|
(0)
N/A
|
(1)
-103%
|
(1)
-39%
|
(2)
-80%
|
(2)
-33%
|
(3)
-1%
|
(3)
-2%
|
(7)
-155%
|
(9)
-39%
|
(11)
-18%
|
(10)
+4%
|
(10)
+3%
|
(8)
+16%
|
(8)
+8%
|
(6)
+22%
|
(5)
+14%
|
(5)
+5%
|
(4)
+10%
|
(4)
+7%
|
(4)
+3%
|
(3)
+15%
|
(3)
+5%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(9)
|
3
|
5
|
6
|
15
|
3
|
4
|
2
|
2
|
4
|
2
|
4
|
4
|
1
|
3
|
2
|
1
|
|
| Non-Reccuring Items |
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
0
|
(2)
|
(1)
|
0
|
0
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(2)
N/A
|
(0)
+81%
|
(1)
-114%
|
(1)
-20%
|
(3)
-257%
|
(3)
+5%
|
(11)
-243%
|
(1)
+90%
|
(3)
-151%
|
(4)
-47%
|
3
N/A
|
(8)
N/A
|
(7)
+13%
|
(7)
-2%
|
(7)
-3%
|
(2)
+69%
|
(3)
-55%
|
(1)
+56%
|
(1)
+50%
|
(3)
-350%
|
(1)
+70%
|
(2)
-89%
|
(2)
-3%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
(19)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(21)
|
(0)
|
(1)
|
(1)
|
(3)
|
(3)
|
(11)
|
(1)
|
(3)
|
(4)
|
3
|
(8)
|
(7)
|
(7)
|
(7)
|
(2)
|
(3)
|
(1)
|
(1)
|
(3)
|
(1)
|
(2)
|
(2)
|
|
| Net Income (Common) |
(21)
N/A
|
(0)
+98%
|
(1)
-114%
|
(1)
-20%
|
(3)
-257%
|
(3)
+5%
|
(11)
-243%
|
(1)
+90%
|
(3)
-151%
|
(4)
-47%
|
3
N/A
|
(8)
N/A
|
(7)
+13%
|
(7)
-2%
|
(7)
-3%
|
(2)
+69%
|
(3)
-55%
|
(1)
+56%
|
(1)
+50%
|
(3)
-350%
|
(1)
+70%
|
(2)
-89%
|
(2)
-3%
|
|
| EPS (Diluted) |
-0.77
N/A
|
-0.05
+94%
|
-0.12
-140%
|
-1.3
-983%
|
-0.41
+68%
|
-0.34
+17%
|
-1.19
-250%
|
-1.06
+11%
|
-0.22
+79%
|
-0.32
-45%
|
0.22
N/A
|
-5.22
N/A
|
-3.48
+33%
|
-3.42
+2%
|
-3.5
-2%
|
-1.09
+69%
|
-1.37
-26%
|
-0.5
+64%
|
-0.25
+50%
|
-1.15
-360%
|
-0.26
+77%
|
-0.49
-88%
|
-0.4
+18%
|
|